<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04485312</url>
  </required_header>
  <id_info>
    <org_study_id>abcxyz</org_study_id>
    <nct_id>NCT04485312</nct_id>
  </id_info>
  <brief_title>Efficacy of Adding Chlorhexidine Varnish to the Preventive Protocol for Caries Assesment for Adolescent Special Needs</brief_title>
  <official_title>Efficacy of Adding Chlorhexidine Containing Chemotherapeutic Agent to the Conventional Preventive Protocol in Evaluation of Caries Risk Assessment for Patients With Special Needs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adolescent Special need individuals are most need of easy forms of antibacterial agents, so
      in this study, using chemotherapeutic agents like the newly introduced varnish containing
      chlorhexidine seems to be a quite promising tool for local delivery to patients with special
      needs . Chlorhexidine is a wide spectrum very effective bactericidal used for years against
      the oral flora while fluorides are well known with their antibacterial ability. This may be
      an excellent way to reduce the risk assessment in adolescent special needs patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be divided into two groups according to the tested regimen, where (A1)
      represents participants exposed to risk based conventional protocol, (A2) represents
      participants exposed to chlorhexidine containing varnish and risk based conventional
      preventive protocol. The study will be carried over a period of 10 months (one academic
      year), the study will be divided into three phases Phase I: Information of the Cariogram
      parameters (caries experience, diet content, diet frequency, plaque amount, mutans
      streptococci, fluoride program, saliva secretion and saliva buffer capacity) will be
      collected, which will be used to generate the individual caries profile, based on which the
      participants will be divided into 2 risks groups. Phase II: Risk based preventive program
      will be implemented including the restorative part. Phase III: At the end of 10 months,
      caries profile will be generated again
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 15, 2020</start_date>
  <completion_date type="Anticipated">August 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>chance to avoid new caries</measure>
    <time_frame>10 months</time_frame>
    <description>% of the green sector in the cariogram</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cariogram parameters</measure>
    <time_frame>10 months</time_frame>
    <description>% of each parameter in the cariogram model</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Disabilities Multiple</condition>
  <arm_group>
    <arm_group_label>caries preventive protocol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>preventive protocol for special needs ( tooth brushing , topical fluoride and mouth wash)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>chlorhexidine varnish added to the caries preventive protocol</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>chlorhexidine varnish preventive caries protocol for special needs</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>preventive protocol</intervention_name>
    <description>preventive protocol</description>
    <arm_group_label>caries preventive protocol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>chlorhexidine added to the preventive protocol</intervention_name>
    <description>chlorhexidine varnish added to the preventive protocol</description>
    <arm_group_label>chlorhexidine varnish added to the caries preventive protocol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of disability like : autism and down syndrome.

          -  Must be able to open his/her mouth for varnish application

        Exclusion Criteria:

          -  systemically unhealthy patients with fetal diseases

          -  Age below 13 and above 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>katreen tawfik, master</last_name>
    <role>Principal Investigator</role>
    <affiliation>cairo U</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>katreen tawfik, master</last_name>
    <phone>002/01204419386</phone>
    <email>koutylovelygirl@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>katreen tawfik, master</last_name>
    <phone>01555572155</phone>
    <email>katreen.tawfik@dentistry.cu.edu</email>
  </overall_contact_backup>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 18, 2020</study_first_submitted>
  <study_first_submitted_qc>July 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2020</study_first_posted>
  <last_update_submitted>July 23, 2020</last_update_submitted>
  <last_update_submitted_qc>July 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Katreen Tawfik</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>publications in journal</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>1 year</ipd_time_frame>
    <ipd_access_criteria>online access</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

